NOCILBSENOCIL LtdMediumNeutral
Announced Fri, 15 May · 10:18 IST

Announcement under Regulation 30 (LODR)- Earnings Call Transcript

Mgmt Guided Margin ImprovementMgmt Guided Margin PressureOrder Pipeline DisclosedInvestor Communications View source PDF

NOCIL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-3.0%1-day move
₹167.03
prior close
₹167.00
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.1+1.3+0.6+1.0-3.0+2.1+0.0-0.7+0.4+1.1-7.0-2.3-0.6
Up moveDown movePending
AI summary

NOCIL reported Q4 FY'26 revenue of Rs.330 crores with 7% sequential volume growth, achieving a volume index of 150 - the second-highest in 4 years. Full year FY'26 revenue stood at Rs.1,303 crores versus Rs.1,393 crores in FY'25. Operating EBITDA margin compressed to 6.4% in Q4 (Rs.21 crores) and 7.7% for the full year (Rs.101 crores), impacted by rising raw material costs (aniline prices jumped from Rs.110 to Rs.190/kg) and legacy inventory issues. Management noted pricing pressure from imports, though DGTR has recommended antidumping duties on TDQ and Sulphenamides (pending government approval). The Rs.250 crores Dahej TDQ capex has been completed with trial production underway, while a new Rs.130 crores capex for specialty rubber chemicals is expected by H1'FY28. Management guided they expect to improve EBITDA by 150 basis points going forward from FY'26 base levels.

Likely market impact

NOCIL faces near-term margin pressure from raw material inflation and import competition, but upcoming antidumping duties and new capacity additions could support recovery. The company's working capital improvements and cost optimization initiatives provide some cushion against industry headwinds.